- Alibaba Health reported its first-half revenue as 14.27 billion yuan.
- This revenue figure was below the estimated 14.57 billion yuan.
- The company achieved a net income of 769 million yuan.
- The gross profit margin was higher than expected at 24.8%, surpassing the estimate of 22.5%.
- Analyst recommendations consist of 17 buys, 4 holds, and 1 sell.
“`
Alibaba Health Information Tec on Smartkarma
Analyst coverage on Alibaba Health Information Tec on Smartkarma by David Mudd highlights the company’s positive growth within the online healthcare industry in China. With a close relationship to parent company Alibaba, Ali Health has seen an increase in revenue and profitability. Operating an online platform for healthcare services and products, the company has capitalized on the expanding online healthcare market post-COVID. Recent financial results exceeding analyst expectations, with a 65% rise in net profit, further demonstrate the company’s strength. Additionally, the acquisition of AJK Technology from Taobao provides operational rights for advertising online healthcare merchants on Tmall, enhancing Alibaba Health Information Tec‘s strategic position.
A look at Alibaba Health Information Tec Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 2 | |
Dividend | 1 | |
Growth | 5 | |
Resilience | 5 | |
Momentum | 5 | |
OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
An analysis of Alibaba Health Information Technology Limited based on Smartkarma Smart Scores reveals a positive long-term outlook for the company. With a strong emphasis on growth, resilience, and momentum, Alibaba Health Information Tec positions itself favorably in the market. The company’s high scores in growth and resilience indicators suggest a promising future in terms of expansion and ability to withstand market challenges.
Additionally, Alibaba Health Information Tec‘s momentum score highlights its current favorable market performance, indicating a positive trend that could lead to further success. While the company may have lower scores in value and dividend factors, its strengths in growth, resilience, and momentum make it a promising player in the healthcare information sector. Overall, Alibaba Health Information Tec‘s Smartkarma Smart Scores point towards a bright future for the integrated healthcare information and content service provider.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars